Difficulty: Medium
Average Score: 91%
Practice
Which of the following barbiturates is preferred as a sedative agent in a patient having liver disease?
Correct answer
C
Rationale
In patients with liver disease, the preferred sedative agent among the listed barbiturates is Phenobarbital (option C). This preference is due to its primarily hepatic metabolism, making it a safer choice as it is less reliant on liver function for clearance.
Allobarbitone (option A), Cyclobarbitone (option B), and Pentobarbital (option D) are metabolized predominantly in the liver, and their clearance may be impaired in patients with liver disease, leading to potential drug accumulation and increased risk of toxicity.
Educationally, understanding the pharmacokinetics of CNS drugs is crucial for clinical decision-making, especially in patients with hepatic impairment. This knowledge helps healthcare professionals select appropriate medications to minimize adverse effects and ensure optimal therapeutic outcomes. Thus, recognizing the preferred agent in such scenarios improves patient safety and quality of care.
Allobarbitone (option A), Cyclobarbitone (option B), and Pentobarbital (option D) are metabolized predominantly in the liver, and their clearance may be impaired in patients with liver disease, leading to potential drug accumulation and increased risk of toxicity.
Educationally, understanding the pharmacokinetics of CNS drugs is crucial for clinical decision-making, especially in patients with hepatic impairment. This knowledge helps healthcare professionals select appropriate medications to minimize adverse effects and ensure optimal therapeutic outcomes. Thus, recognizing the preferred agent in such scenarios improves patient safety and quality of care.